Our results show that not only the systematic Slc38a6 knock-out but also Slc38a6 specific knock-out in LyzCRE cells could ameliorate LPS induced sepsis-associated pulmonary inflammation severity, and decrease inflammatory cytokines, such as TNF-α and IL-1β. The gene discussed is SLC38A6; the disease is Sepsis.